Radioactive main group and rare earth metals for imaging and therapy

TI Kostelnik, C Orvig - Chemical reviews, 2018 - ACS Publications
Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …

The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society

JR Howe, K Cardona, DL Fraker, E Kebebew… - Pancreas, 2017 - journals.lww.com
Small bowel neuroendocrine tumors (SBNETs) have been increasing in frequency over the
past decades, and are now the most common type of small bowel tumor. Consequently …

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

MF Bozkurt, I Virgolini, S Balogova, M Beheshti… - European journal of …, 2017 - Springer
Abstract Purpose & Methods Neuroendocrine neoplasms are a heterogenous group of
tumours, for which nuclear medicine plays an important role in the diagnostic work-up as …

Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation

MS Hofman, WFE Lau, RJ Hicks - Radiographics, 2015 - pubs.rsna.org
Gallium 68 (68Ga) 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA)–
octreotate (DOTATATE, GaTate) positron emission tomography (PET)/computed tomography …

Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors

TA Hope, EK Bergsland, MF Bozkurt… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Somatostatin receptor (SSTR) PET has demonstrated a significant improvement over
conventional imaging (CI) in patients with neuroendocrine tumors (NETs). SSTR PET should …

[HTML][HTML] Prospective study of 68Ga-DOTATATE positron emission tomography/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors …

SM Sadowski, V Neychev, C Millo, J Shih… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Gastro-entero-pancreatic neuroendocrine tumors (GEPNETs) are increasing in
incidence, and accurate staging is important for selecting the appropriate treatment. 68 Ga …

Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT

Y Sanli, I Garg, A Kandathil, T Kendi… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to provide a review of the use of 68Ga
tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a …

[PDF][PDF] SNMMI procedure standard/EANM practice guideline for SSTR PET: imaging neuroendocrine tumors

TA Hope, M Allen-Auerbach, L Bodei… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Somatostatin receptor (SSTR) imaging using PET has replaced scintigraphic imaging using
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET …

Safety and efficacy of 68Ga-DOTATATE PET/CT for diagnosis, staging, and treatment management of neuroendocrine tumors

SA Deppen, E Liu, JD Blume, J Clanton… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Our purpose was to evaluate the safety and efficacy of 68Ga-DOTATATE PET/CT compared
with 111In-pentetreotide imaging for diagnosis, staging, and restaging of pulmonary and …

68Ga-DOTATATE compared with 111In-DTPA-octreotide and conventional imaging for pulmonary and gastroenteropancreatic neuroendocrine tumors: a systematic …

SA Deppen, J Blume, AJ Bobbey, C Shah… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Neuroendocrine tumors (NETs) are uncommon tumors with increasing incidence and
prevalence. Current reports suggest that 68Ga-DOTATATE PET/CT imaging improves …